After more than two decades in China, ESTEVE CDMO marks a new chapter in its commitment to the country and the region.With more than $80 million invested, the new facility brings a new generation of manufacturing capabilities, with 250 m³ of reaction volume and potential capacity of more than 400+ m³.Advanced manufacturing, automation, and digitalization enhance ESTEVE CDMO's capabilities and support its continued growth in Asia.SHAOXING, China, Oct. 21, 2026 /PRNewswire/ — ESTEVE CDMO, Esteve Healthcare contract development and manufacturing organization, is strengthening its presence in Asia through the relocation, expansion and modernization of its existing manufacturing operations in China, supported by an…